revolutionizing
drug accessibility

A global pharmaceutical company committed to revolutionizing drug accessibility
SK-Pharma embraces a patient-centric strategy, immersing ourselves in a comprehensive understanding of the entire patient journey

Our Products
Improve health
equity
by ensuring universal access to vital medications to all patients
Monitor
markets
and collect real-time intelligence and Rare Diseases Data
Improve patient
access
to vital treatments of rare diseases

pharmaceutical scope

In our commitment to being a data-driven, we leverage advanced technologies for intelligent decision-making in product selection, launch strategies, and supply chain optimization.
+
Value-Added Medicines
+
Precision Medicines
+
Orphan Drugs
+
Complex Generics

Keep Up To Date

Sign up to receive Email updates from SK-Pharma.

    Media

    See All
    CEO Articles
    October 6, 2024
    Building a 'Turquoise' Company: The Balance of Trust and Vision
    Read More
    Blog
    July 29, 2024
    Navigating Regulatory Challenges in the Pharmaceutical Industry
    Read More
    Blog
    August 6, 2024
    Sustainability in Pharma: The Path to a Greener Future
    Read More
    Blog
    August 12, 2024
    Vacation Diseases: Staying Healthy While Traveling
    Read More
    News & Events
    August 11, 2024
    Attending CPHI 2024
    Read More
    Blog
    August 22, 2024
    Back to the Grind: Health Tips for Families Getting Back to School Mode
    Read More
    Blog
    August 26, 2024
    Implementing AI in Quality Processes in the Pharmaceutical Field: Pros and Cons
    Read More
    Blog
    Childhood Obesity Awareness Month: A Global Call to Action
    Read More
    Ksenia Sizov Articles
    September 4, 2024
    Scaling Smart: The Critical Role of Reorganization in Company Growth
    Read More
    Ksenia Sizov Articles
    September 11, 2024
    Facing the Fear: Understanding Employee Resistance to Organizational Change
    Read More
    CEO
    July 28, 2024
    Shlomo Sadoun Honorary Global Advisory Board Member appointment at Etherea Global University, USA
    Read More
    CEO Articles
    July 16, 2024
    Supportive Management: Building a Positive Corporate Culture
    Read More
    Blog
    July 15, 2024
    Value-Added Medicines: Enhancing Patient Experience
    Read More
    Blog
    July 14, 2024
    The Role of Data-Driven Solutions in Modern Healthcare
    Read More
    Blog
    July 12, 2024
    Innovations in Hybrid Generics: A New Era in Pharmaceuticals
    Read More
    CEO Articles
    June 12, 2024
    Obesity Market Odyssey Evolving from a Treatment Approach to a Holistic Solution
    Read More
    Blog
    May 8, 2024
    Navigating Leadership with Emotional Intelligence: A Personal Perspective by Ksenia Sizov
    Read More
    News & Events
    June 28, 2024
    Inside SK-Pharma: Insights from the Team Working with Dr. Shlomo Sadoun
    Read More
    Blog
    April 4, 2024
    Navigating the Evolving Regulatory Landscape of Value-Added Generics
    Read More
    Blog
    Affordable Care Redefined: The Emerging Impact of Complex Generics on Global Health
    Read More
    News & Events
    December 18, 2023
    2024 Outlook: Navigating the Future of Pharmaceutical Industry Trends in the MENA Region
    Read More
    Blog
    February 18, 2024
    Are Turquoise Companies the Future of Work?
    Read More
    Press
    February 18, 2024
    The Mission Shorten Rare Diseases Patients Odyssey – Imperative Solutions
    Read More

    Our Companies

    KS-Kim
    KS-Kim
    Our main areas of focus are the registration process for pharmaceutical companies, creation of marketing strategies and maintaining distribution channels for pharmaceutical products in the Israeli market
    Read More
    DrugsIntel
    DrugsIntel
    The DI company has developed an exclusive technological platform, The Compass that aggregates unique data sets and applies manipulation, unification and deployment of the data to BI using AI and ML models.
    Read More
    Orphan Division
    Orphan Division
    SK-Pharma's dedicated Orphan Drug Division excels in global market access and distribution of orphan drugs.
    Read More
    Alzimind
    Alzimind
    Alzimind is a leader in precision medicine, focusing on early detection of dementia (EDD). As a Health Center of Excellence (HCOE), we aim to implement evidence-based methods to enhance the early detection of Alzheimer’s Disease.
    Read More
    Obesio
    Obesio
    Obesio harnesses the power of advanced machine learning techniques in order to provide a personalized approach to weight loss.
    Read More

    about us

    SK-Pharma is a pioneering global pharmaceutical company that provides and launches value-added medicines, complex generics, and patient-centric healthcare solutions. Our mission is to enhance
    well-being by ensuring essential medicines are accessible to all patients, particularly those in need.
    Read More

    Our Partners

    We are committed to collaborating and building enduring relationships with key players in the biopharmaceutical industry.
    Elpen
    Rafarm logo
    ANFARM LOGO
    Intas B2B logo

    Global Reach

    SK-Pharma is a dynamic and progressive player in the global pharmaceutical landscape
    Israel
    + -

    Address:

    Alon 2 Tower, 38th floor

    94 Yigal Alon St,Tel Aviv, P.O. 146

    Israel 6789139

    Phone: +972-3-6114543

    Fax: +972-3-7512601

    Serbia
    + -

    Address:

    Krunska 80/7
    11000 Belgrade, Serbia

    Phone: +381-11-4094677

    Switzerland
    Russia
    Malta
    + -

    Address:

    Alpharma, SB Business Centre, Dun Karm St.
    Birkirkara Bypass, Birkirkara, Malta
    Kazakhstan
    Belarus
    + -

    Address:

    Kirov str. 8 office 34
    Republic of Belarus, Minsk, 220030

    Accessibility Toolbar